Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G G Chabot

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Cancer Research|August 1, 1988
Acodazole hydrochloride: phase I trial, pharmacokinetics, and evaluation of cardiotoxicity in dogsR Pazdur, G G Chabot, C A Campbell, et al.
Cancer Research|October 1, 1993
Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissuesC Toussaint, N Albin, L Massaad, et al.
Investigational New Drugs|February 1, 1991
Crisnatol mesylate: phase I dose escalation by extending infusion durationE A Poplin, G G Chabot, R L Tuttle, et al.
Cancer Research|March 1, 1988
Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivoM C Bissery, F A Valeriote, G G Chabot, et al.
Journal of Chromatography|March 27, 1992
Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patientsI Barilero, D Gandia, J P Armand, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II and pharmacokinetic study of fotemustine in inoperable colorectal cancerP Rougier, G G Chabot, J Bonneterre, et al.
Cancer Research|August 1, 1993
Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissuesN Albin, L Massaad, C Toussaint, et al.
Bulletin Du Cancer|May 1, 1993
[Screening of principal enzymes involved in the metabolism of anticancer drugs in human and murine colonic tumors]L Massaad, I de Waziers, V Ribrag, et al.
Journal of the National Cancer Institute|March 16, 1994
Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrheaD Abigerges, J P Armand, G G Chabot, et al.
Cancer Research|December 1, 1992
Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systemsL Massaad, I de Waziers, V Ribrag, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cancer Research|August 1, 1988
Acodazole hydrochloride: phase I trial, pharmacokinetics, and evaluation of cardiotoxicity in dogsR Pazdur, G G Chabot, C A Campbell, et al.
Cancer Research|October 1, 1993
Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissuesC Toussaint, N Albin, L Massaad, et al.
Investigational New Drugs|February 1, 1991
Crisnatol mesylate: phase I dose escalation by extending infusion durationE A Poplin, G G Chabot, R L Tuttle, et al.
Cancer Research|March 1, 1988
Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivoM C Bissery, F A Valeriote, G G Chabot, et al.
Journal of Chromatography|March 27, 1992
Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patientsI Barilero, D Gandia, J P Armand, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II and pharmacokinetic study of fotemustine in inoperable colorectal cancerP Rougier, G G Chabot, J Bonneterre, et al.
Cancer Research|August 1, 1993
Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissuesN Albin, L Massaad, C Toussaint, et al.
Bulletin Du Cancer|May 1, 1993
[Screening of principal enzymes involved in the metabolism of anticancer drugs in human and murine colonic tumors]L Massaad, I de Waziers, V Ribrag, et al.
Journal of the National Cancer Institute|March 16, 1994
Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrheaD Abigerges, J P Armand, G G Chabot, et al.
Cancer Research|December 1, 1992
Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systemsL Massaad, I de Waziers, V Ribrag, et al.
Pageof 6